Literature DB >> 17482945

Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the first year of life.

Thomas J Walsh1, Stephanie Hsieh, Richard Grady, Beth A Mueller.   

Abstract

OBJECTIVES: To assess the risk of hospitalization for pyelonephritis within the first year of life among infants with and without antenatal hydronephrosis.
METHODS: A retrospective cohort analysis was performed using linked birth-hospital discharge records from Washington State for 1987 to 2002 to evaluate the risk of hospitalization in the first year of life for pyelonephritis among infants with and without hydronephrosis. Eligible infants had mothers who had prenatal ultrasound screening. A total of 522 singleton infants with antenatal hydronephrosis (International Classification of Diseases, Ninth Revision code 753.2) at the birth hospitalization were identified. For comparison, 2610 singletons without hydronephrosis were selected. We screened hospital discharge records for 1 year after delivery to identify hospitalizations for pyelonephritis and estimate the relative risk (RR) among infants with and without hydronephrosis.
RESULTS: Five percent of infants with antenatal hydronephrosis and 1% of those without had pyelonephritis-related hospitalizations in their first year (RR 11.8, 95% confidence interval [CI] 6.8 to 20.5). Among girls the RR was 36.3 (95% CI 10.6 to 124.0); among boys it was 5.3 (95% CI 2.2 to 13.1). In infants with hydronephrosis, girls were more likely to be hospitalized with pyelonephritis (odds ratio 2.9, 95% CI 1.2 to 6.9).
CONCLUSIONS: Infants with antenatal hydronephrosis are nearly 12 times more likely to have pyelonephritis-related hospitalizations in the first year of life. This association is stronger in girls. Parents and healthcare providers of infants with this diagnosis should be vigilant for the signs and symptoms of urinary tract infections.

Entities:  

Mesh:

Year:  2007        PMID: 17482945     DOI: 10.1016/j.urology.2007.01.062

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

Review 1.  Antibiotic prophylaxis for prevention of urinary tract infections in prenatal hydronephrosis: An updated systematic review.

Authors:  Bethany Easterbrook; John-Paul Capolicchio; Luis H Braga
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 2.  Continuous antibiotic prophylaxis in the setting of prenatal hydronephrosis and vesicoureteral reflux.

Authors:  Nathan C Wong; Martin A Koyle; Luis H Braga
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

3.  [Congenital dilatation of the upper urinary tract : Current diagnostic and treatment concepts].

Authors:  R Beetz
Journal:  Urologe A       Date:  2018-08       Impact factor: 0.639

4.  [Primary megaureter].

Authors:  P Anheuser; J Kranz; J Steffens; R Beetz
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

5.  Clinical course of 822 children with prenatally detected nephrouropathies.

Authors:  Isabel G Quirino; Jose Silverio S Diniz; Maria Candida F Bouzada; Alamanda K Pereira; Thais J Lopes; Gabriela M Paixão; Natalia N Barros; Luisa C Figueiredo; Antonio Carlos V Cabral; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 8.237

6.  Primary non-refluxive megaureter in children: single-center experience and follow-up of 212 patients.

Authors:  P Rubenwolf; J Herrmann-Nuber; M Schreckenberger; R Stein; R Beetz
Journal:  Int Urol Nephrol       Date:  2016-08-04       Impact factor: 2.370

Review 7.  Antenatally diagnosed hydronephrosis: current postnatal management.

Authors:  Michael T Davenport; Paul A Merguerian; Martin Koyle
Journal:  Pediatr Surg Int       Date:  2013-01-17       Impact factor: 1.827

Review 8.  Environmental factors for the development of fetal urinary malformations.

Authors:  Ming-Yan Hei; Zhu-Wen Yi
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

Review 9.  Primary neonatal MRSA pyonephrosis.

Authors:  Ramnik Patel; Ngozi Nwokoma; George K Ninan
Journal:  Int Urol Nephrol       Date:  2012-08-21       Impact factor: 2.370

10.  Severity of birth defects after propylthiouracil exposure in early pregnancy.

Authors:  Stine Linding Andersen; Jørn Olsen; Chun Sen Wu; Peter Laurberg
Journal:  Thyroid       Date:  2014-06-25       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.